This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bagel, S.
Right arrow Articles by Heisig, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bagel, S.
Right arrow Articles by Heisig, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 1999, p. 868-875, Vol. 43, No. 4
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Impact of gyrA and parC Mutations on Quinolone Resistance, Doubling Time, and Supercoiling Degree of Escherichia coli

Simone Bagel, Volker Hüllen, Bernd Wiedemann, and Peter Heisig*

Pharmazeutische Mikrobiologie, Universität Bonn, 53115 Bonn, Germany

Received 22 June 1998/Returned for modification 11 August 1998/Accepted 8 February 1999

Isogenic mutants derived from quinolone-susceptible isolate WT by introducing gyrA (S83L, D87G) and parC (S80I, E84K) mutations associated with quinolone resistance were characterized with respect to quinolone resistance, growth rate, and degree of global supercoiling. The latter was determined by use of a pair of reporter plasmids carrying supercoiling-dependent promoters pgyrA and ptopA, respectively, transcriptionally fused to the reporter gene bla coding for TEM-1 beta -lactamase. The quotient (Qsc) of the beta -lactamase specific activity determined for a mutant carrying either plasmid was taken as a measure of the degree of global supercoiling. These Qsc data were comparable to results obtained from the separation of topoisomers of plasmid pBR322 on chloroquine-containing agarose gels and indicate a reduced degree of negative supercoiling in resistant mutants relative to the parent, WT. The S83L mutation in gyrA had the strongest influence on quinolone resistance while leaving other parameters nearly unaffected. The gyrA double mutation (S83L plus D87G) had an effect on quinolone resistance similar to that of a single mutation. Phenotypic expression of the parC mutation (S80I) was dependent on the presence of at least one gyrA mutation. Expression of high-level fluoroquinolone resistance (ciprofloxacin MIC, >4 µg/ml) required a combination of the gyrA double mutation and one parC mutation (S80I or E84K). Such mutants showed considerable alterations of growth rate, global supercoiling, or both. Introduction of a parC mutation affected neither the doubling time nor the degree of supercoiling, while the presence of the gyrA D87G mutation was associated with a significant reduction in the degree of DNA supercoiling.


* Corresponding author. Mailing address: Pharmazeutische Mikrobiologie, Universität Bonn, Meckenheimer Allee 168, 53115 Bonn, Germany. Phone: 49-228-735247. Fax: 49-228-735267. E-mail: peter.heisig{at}uni-bonn.de.


Antimicrobial Agents and Chemotherapy, April 1999, p. 868-875, Vol. 43, No. 4
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Cambau, E., Matrat, S., Pan, X.-S., Roth Dit Bettoni, R., Corbel, C., Aubry, A., Lascols, C., Driot, J.-Y., Fisher, L. M. (2009). Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli. J Antimicrob Chemother 63: 443-450 [Abstract] [Full Text]  
  • Preisler, A., Heisig, P. (2009). The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G). J Antimicrob Chemother 63: 290-294 [Abstract] [Full Text]  
  • Morgan-Linnell, S. K., Becnel Boyd, L., Steffen, D., Zechiedrich, L. (2009). Mechanisms Accounting for Fluoroquinolone Resistance in Escherichia coli Clinical Isolates. Antimicrob. Agents Chemother. 53: 235-241 [Abstract] [Full Text]  
  • Tamae, C., Liu, A., Kim, K., Sitz, D., Hong, J., Becket, E., Bui, A., Solaimani, P., Tran, K. P., Yang, H., Miller, J. H. (2008). Determination of Antibiotic Hypersensitivity among 4,000 Single-Gene-Knockout Mutants of Escherichia coli. J. Bacteriol. 190: 5981-5988 [Abstract] [Full Text]  
  • Pope, C. F., Gillespie, S. H., Pratten, J. R., McHugh, T. D. (2008). Fluoroquinolone-Resistant Mutants of Burkholderia cepacia. Antimicrob. Agents Chemother. 52: 1201-1203 [Abstract] [Full Text]  
  • Piatti, G., Mannini, A., Balistreri, M., Schito, A. M. (2008). Virulence Factors in Urinary Escherichia coli Strains: Phylogenetic Background and Quinolone and Fluoroquinolone Resistance. J. Clin. Microbiol. 46: 480-487 [Abstract] [Full Text]  
  • Morgan-Linnell, S. K., Zechiedrich, L. (2007). Contributions of the Combined Effects of Topoisomerase Mutations toward Fluoroquinolone Resistance in Escherichia coli. Antimicrob. Agents Chemother. 51: 4205-4208 [Abstract] [Full Text]  
  • Biswas, S., Raoult, D., Rolain, J.-M. (2007). Molecular mechanisms of resistance to antibiotics in Bartonella bacilliformis. J Antimicrob Chemother 59: 1065-1070 [Abstract] [Full Text]  
  • Chen, S., Cui, S., McDermott, P. F., Zhao, S., White, D. G., Paulsen, I., Meng, J. (2007). Contribution of Target Gene Mutations and Efflux to Decreased Susceptibility of Salmonella enterica Serovar Typhimurium to Fluoroquinolones and Other Antimicrobials. Antimicrob. Agents Chemother. 51: 535-542 [Abstract] [Full Text]  
  • Bhagwat, S. S., Mundkur, L. A., Gupte, S. V., Patel, M. V., Khorakiwala, H. F. (2006). The Anti-Methicillin-Resistant Staphylococcus aureus Quinolone WCK 771 Has Potent Activity against Sequentially Selected Mutants, Has a Narrow Mutant Selection Window against Quinolone-Resistant Staphylococcus aureus, and Preferentially Targets DNA Gyrase . Antimicrob. Agents Chemother. 50: 3568-3579 [Abstract] [Full Text]  
  • Turner, A. K., Nair, S., Wain, J. (2006). The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets. J Antimicrob Chemother 58: 733-740 [Abstract] [Full Text]  
  • Kim, C., Cha, J. Y., Yan, H., Vakulenko, S. B., Mobashery, S. (2006). Hydrolysis of ATP by Aminoglycoside 3'-Phosphotransferases: AN UNEXPECTED COST TO BACTERIA FOR HARBORING AN ANTIBIOTIC RESISTANCE ENZYME. J. Biol. Chem. 281: 6964-6969 [Abstract] [Full Text]  
  • Preisler, A., Mraheil, M. A., Heisig, P. (2006). Role of novel gyrA mutations in the suppression of the fluoroquinolone resistance genotype of vaccine strain Salmonella Typhimurium vacT (gyrA D87G). J Antimicrob Chemother 57: 430-436 [Abstract] [Full Text]  
  • Wetzstein, H.-G. (2005). Comparative Mutant Prevention Concentrations of Pradofloxacin and Other Veterinary Fluoroquinolones Indicate Differing Potentials in Preventing Selection of Resistance. Antimicrob. Agents Chemother. 49: 4166-4173 [Abstract] [Full Text]  
  • Korzheva, N., Davies, T. A., Goldschmidt, R. (2005). Novel Ser79Leu and Ser81Ile Substitutions in the Quinolone Resistance-Determining Regions of ParC Topoisomerase IV and GyrA DNA Gyrase Subunits from Recent Fluoroquinolone-Resistant Streptococcus pneumoniae Clinical Isolates. Antimicrob. Agents Chemother. 49: 2479-2486 [Abstract] [Full Text]  
  • Kugelberg, E., Lofmark, S., Wretlind, B., Andersson, D. I. (2005). Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa. J Antimicrob Chemother 55: 22-30 [Abstract] [Full Text]  
  • Yu, X., Susa, M., Knabbe, C., Schmid, R. D., Bachmann, T. T. (2004). Development and Validation of a Diagnostic DNA Microarray To Detect Quinolone-Resistant Escherichia coli among Clinical Isolates. J. Clin. Microbiol. 42: 4083-4091 [Abstract] [Full Text]  
  • Giraud, E., Blanc, G., Bouju-Albert, A., Weill, F.-X., Donnay-Moreno, C. (2004). Mechanisms of quinolone resistance and clonal relationship among Aeromonas salmonicida strains isolated from reared fish with furunculosis. J Med Microbiol 53: 895-901 [Abstract] [Full Text]  
  • Yang, H., Chen, S., White, D. G., Zhao, S., McDermott, P., Walker, R., Meng, J. (2004). Characterization of Multiple-Antimicrobial-Resistant Escherichia coli Isolates from Diseased Chickens and Swine in China. J. Clin. Microbiol. 42: 3483-3489 [Abstract] [Full Text]  
  • Ricci, V., Peterson, M. L., Rotschafer, J. C., Wexler, H., Piddock, L. J. V. (2004). Role of Topoisomerase Mutations and Efflux in Fluoroquinolone Resistance of Bacteroides fragilis Clinical Isolates and Laboratory Mutants. Antimicrob. Agents Chemother. 48: 1344-1346 [Abstract] [Full Text]  
  • Baucheron, S., Chaslus-Dancla, E., Cloeckaert, A. (2004). Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204. J Antimicrob Chemother 53: 657-659 [Abstract] [Full Text]  
  • Rapp, R. P, Campion, J. J (2003). Challenges in Pharmacodynamic Studies of Antimicrobial Resistance. The Annals of Pharmacotherapy 37: 1329-1330 [Full Text]  
  • Giraud, E., Cloeckaert, A., Baucheron, S., Mouline, C., Chaslus-Dancla, E. (2003). Fitness cost of fluoroquinolone resistance in Salmonella enterica serovar Typhimurium. J Med Microbiol 52: 697-703 [Abstract] [Full Text]  
  • Martinez-Martinez, L., Pascual, A., Garcia, I., Tran, J., Jacoby, G. A. (2003). Interaction of plasmid and host quinolone resistance. J Antimicrob Chemother 51: 1037-1039 [Full Text]  
  • Minnick, M. F., Wilson, Z. R., Smitherman, L. S., Samuels, D. S. (2003). gyrA Mutations in Ciprofloxacin-Resistant Bartonella bacilliformis Strains Obtained In Vitro. Antimicrob. Agents Chemother. 47: 383-386 [Abstract] [Full Text]  
  • Martinez, J. L., Baquero, F. (2002). Interactions among Strategies Associated with Bacterial Infection: Pathogenicity, Epidemicity, and Antibiotic Resistance. Clin. Microbiol. Rev. 15: 647-679 [Abstract] [Full Text]  
  • Miller, K., O'Neill, A. J., Chopra, I. (2002). Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. J Antimicrob Chemother 49: 925-934 [Abstract] [Full Text]  
  • Goni-Urriza, M., Arpin, C., Capdepuy, M., Dubois, V., Caumette, P., Quentin, C. (2002). Type II Topoisomerase Quinolone Resistance-Determining Regions of Aeromonas caviae, A. hydrophila, and A. sobria Complexes and Mutations Associated with Quinolone Resistance. Antimicrob. Agents Chemother. 46: 350-359 [Abstract] [Full Text]  
  • Jellen-Ritter, A. S., Kern, W. V. (2001). Enhanced Expression of the Multidrug Efflux Pumps AcrAB and AcrEF Associated with Insertion Element Transposition in Escherichia coli Mutants Selected with a Fluoroquinolone. Antimicrob. Agents Chemother. 45: 1467-1472 [Abstract] [Full Text]  
  • Wang, H., Dzink-Fox, J. L., Chen, M., Levy, S. B. (2001). Genetic Characterization of Highly Fluoroquinolone-Resistant Clinical Escherichia coli Strains from China: Role of acrR Mutations. Antimicrob. Agents Chemother. 45: 1515-1521 [Abstract] [Full Text]  
  • Schulte, A., Heisig, P. (2000). In vitro activity of gemifloxacin and five other fluoroquinolones against defined isogenic mutants of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 46: 1037-1038 [Full Text]  
  • Boon, R. J., Bacon, T. H., Robey, H. L., Coleman, T. J., Connolly, A, Crosson, P., Sacks, S. L. (2000). Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialie: a UK-based survey. J Antimicrob Chemother 46: 324-325 [Full Text]  
  • Kern, W. V., Oethinger, M., Jellen-Ritter, A. S., Levy, S. B. (2000). Non-Target Gene Mutations in the Development of Fluoroquinolone Resistance in Escherichia coli. Antimicrob. Agents Chemother. 44: 814-820 [Abstract] [Full Text]